Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Standardization of a flow cytometry SARS-CoV-2 serologic test.

Authors:
Carl Simard Jonathan Richard Renée Bazin Andrés Finzi Patrick Trépanier

Cytotechnology 2022 Feb 3;74(1):99-103. Epub 2022 Jan 3.

Affaires Médicales et Innovation, Héma-Québec, 1070 Avenue des Sciences-de-la-Vie, Québec, QC G1V 5C3 Canada.

The SARS-CoV-2 virus is the causing agent of the coronavirus disease 2019 (COVID-19) pandemic responsible for millions of deaths worldwide. The development of the humoral response to the virus has been the subject of intensive research. A flow cytometry-based assay using native full-length SARS-CoV-2 Spike protein expressed in 293 T cells was recently proposed as a complementary seropositivity assay. The aim of our study was to further develop the flow cytometry assay and to standardize its parameters for reliable inter-laboratory use. We have optimized the protocol, established the Receiving Operating Characteristic (ROC) curve and tested reproducibility using pre-COVID and convalescent, SARS-CoV-2 individual plasma samples. The flow-based assay was simplified and standardized by cultivating the 293 T cells in suspension and expressing results in Mean Equivalent Soluble Fluorochrome (MESF) using an internal antibody positive control. The ROC curve was determined with an area under the curve (AUC) of 0.996 and the assay specificity and sensitivity were established at 100% and 97.7% respectively. Reproducibility was good as determined on multiple cytometers, on different days, and with data acquisition as far as 72 h post-staining. The standardized assay could be used as a high throughput confirmatory assay in flow cytometry laboratories involved in serological testing.

Supplementary Information: The online version contains supplementary material available at 10.1007/s10616-021-00511-1.

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s10616-021-00511-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720558PMC
February 2022

Publication Analysis

Top Keywords

flow cytometry
12
293 t cells
8
roc curve
8
assay
7
material 101007/s10616-021-00511-1
4
study develop
4
control roc
4
reliable inter-laboratory
4
parameters reliable
4
curve determined
4
standardize parameters
4
determined area
4
assay standardize
4
area curve
4
cytometry assay
4
develop flow
4
auc 0996
4
curve auc
4
aim study
4
positive control
4

Keyword Occurance

Similar Publications

Comparison Study on the Effect of Mesenchymal Stem Cells-Conditioned Medium Derived from Adipose and Wharton's Jelly on Versican Gene Expression in Hypoxia.

Authors:
Maryam Khani Bernard Burke Marzieh Ebrahimi Shiva Irani Fattah Sotoodehnejad

Iran Biomed J 2022 May 22. Epub 2022 May 22.

Department of Biology, School of Basic Science, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Background: Mesenchymal stem cells enhance tissue repair through paracrine effects following transplantation. The versican protein is one of the important factors contributing to this repair mechanism. Using MSC conditioned medium for cultivating monocytes may increase versican protein production and could be a good alternative for ansplantation of MSCs. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

P-selectin glycoprotein ligand-1 (PSGL-1/CD162) is incorporated into clinical HIV-1 isolates and can mediate virus capture and subsequent transfer to permissive cells.

Authors:
Jonathan Burnie Arvin Tejnarine Persaud Laxshaginee Thaya Qingbo Liu Huiyi Miao Stephen Grabinsky Vanessa Norouzi Paolo Lusso Vera A Tang Christina Guzzo

Retrovirology 2022 May 21;19(1). Epub 2022 May 21.

Department of Biological Sciences, University of Toronto Scarborough, 1265 Military Trail, Toronto, ON, Canada.

Background: P-selectin glycoprotein ligand-1 (PSGL-1/CD162) has been studied extensively for its role in mediating leukocyte rolling through interactions with its cognate receptor, P-selectin. Recently, PSGL-1 was identified as a novel HIV-1 host restriction factor, particularly when expressed at high levels in the HIV envelope. Importantly, while the potent antiviral activity of PSGL-1 has been clearly demonstrated in various complementary model systems, the breadth of PSGL-1 incorporation across genetically diverse viral isolates and clinical isolates has yet to be described. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Identification of excretory and secretory proteins from Haemonchus contortus inducing a Th9 immune response in goats.

Authors:
Meng Liang Mingmin Lu Muhammad Tahir Aleem Yang Zhang Mingyue Wang Zhaohai Wen Xiaokai Song Lixin Xu Xiangrui Li Ruofeng Yan

Vet Res 2022 May 21;53(1):36. Epub 2022 May 21.

MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, 210095, Jiangsu, China.

Th9 cells have been shown to play crucial roles in anti-parasite immunity, pathogenic microbe infection, and allergy. Previous studies have demonstrated that Haemonchus contortus excretory and secretory proteins (HcESPs) induce the proliferation of Th9 cells and alter the transcriptional level of IL-9 as well as its related pathways in the Th9 immune response after infection. However, the exact molecule(s) in HcESPs inducing the Th9 immune response is not yet known. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Targeting epidermal growth factor receptor in paclitaxel-resistant human breast and lung cancer cells with upregulated glucose-6-phosphate dehydrogenase.

Authors:
Hye-Young Min Ho Jin Lee Young-Ah Suh Honglan Pei Hyukjin Kwon Hyun-Ji Jang Hye Jeong Yun Hyeong-Gon Moon Ho-Young Lee

Br J Cancer 2022 May 21. Epub 2022 May 21.

College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea.

Background: Chemoresistance is a major obstacle to the successful treatment of triple-negative breast cancer (TNBC) and non-small-cell lung cancer (NSCLC). Therapeutic strategies to overcome chemoresistance are necessary to improve the prognosis of patients with these cancers.

Methods: Paclitaxel-resistant TNBC and NSCLC sublines were generated through continuous paclitaxel treatment over 6 months. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

TXN inhibitor impedes radioresistance of colorectal cancer cells with decreased ALDH1L2 expression via TXN/NF-κB signaling pathway.

Authors:
Lu Yu Qiqing Guo Ziqian Luo Yongjia Wang Jiawen Weng Yuchuan Chen Weijie Liang Yiyi Li Yuqin Zhang Keli Chen Zhenhui Chen Yi Ding Yaowei Zhang

Br J Cancer 2022 May 21. Epub 2022 May 21.

Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Background: Colorectal cancer (CRC) is prevalent worldwide and is often challenged by treatment failure and recurrence due to resistance to radiotherapy. Here, we aimed to identify the elusive underlying molecular mechanisms of radioresistance in CRC.

Methods: Weighted gene co-expression network analysis was used to identify potential radiation-related genes. Read More

View Article and Full-Text PDF
May 2022
Similar Publications
}